NIVFNasdaqServices-Misc Health & Allied Services, NECAlso trades as NIVFW
NewGenIvf Group Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$0.28+0.00 (+1.47%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
Share price
−$2,656.5966 (−99.99%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
NewGenIvf Group Ltd saw revenue fall 13.0% to $4.73M over fiscal 2025. Free cash flow was -$11.06M.
Revenue
$4.73M
-13.0% vs. a year earlier
Operating income
-$10.73M
FY2025
Free cash flow
-$11.06M
FY2025
EPS, diluted
$3.04
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- 0.1
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $4.73M
- Net income
- $9.88M
- EPS, diluted
- $3.04
- Free cash flow
- -$11.06M
Six years at a glance
Fiscal years 2020 to 2025, USD
Revenue
$4.73M-13.0% YoY
Gross profit
$955.85K-47.7% YoY
Operating income
-$10.73M
Net income
$9.88M
EPS, diluted
$3.04
Free cash flow
-$11.06M
Reported period